ASX Share rice
Wed 05 Aug 2020 - 11:58:pm (Sydney)

RGS Share Price

REGENEUS LTDRGSPharmaceuticals, Biotechnology & Life Sciences

RGS Company Information


Regeneus Ltd





GIC Industry:


GIC Sub Industry:



2 Paddington Street Paddington NSW Australia 2021


61 2 9499 8010

CEO & Exec. Director:

Mr. Leo Lee

Chief Scientific Officer & Exec. Director:

Prof. Graham Vesey

Chief Financial & Operations Officer:

Mr. John Bird

Head of R&D:

Dr. Charlotte Morgan

Company Sec. & Head of Corp. Affairs:

Ms. Sandra McIntosh

Company Overview:

Regeneus Ltd, a clinical-stage regenerative medicine company, engages in developing cell-based therapies for the human and animal health markets with a focus on osteoarthritis and other musculoskeletal disorders, and neuropathic pain and dermatology diseases. The company is developing its therapeutic products using its proprietary stem cell and immuno-oncology technology platforms. Its products under development for human health market include Progenza, a cell therapy that has completed Phase I clinical trial for the treatment of osteoarthritis and other musculoskeletal disorders; RGSH4K, a cancer vaccine, which is in Phase I clinical trial for the treatment of solid tumors; and Sygenus allogeneic cell secretion for use as a topical application for the treatment of acne and other inflammatory skin conditions, and wound healing. The company's animal health products comprise CryoShot, an allogeneic mesenchymal stem cell therapy for the treatment of canine osteoarthritis and other musculoskeletal disorders; and Kvax, an autologous cancer vaccine. Regeneus Ltd was founded in 2007 and is headquartered in Paddington, Australia.

RGS Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Operating Margin (TTM):


Return On Assets (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


RGS CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Change To Inventory:


Capital Expenditures:


RGS Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Interest Expense:


Total Revenue:


Total Operating Expenses:


RGS Balance Sheet

Balance Sheet Date:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:


Other Liabilities:




Total Current Liabilities:


Short-Term Debt:


Property - Plant & Equipment:


Net Tangible Assets:


Long-Term Investments:


Total Current Assets:


Net Receivables:


Short-Term Investments:




Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


RGS Share Price History

RGS News

16 Apr, 2020
Regeneus Ltd (ASX:RGS) shareholders should be happy to see the share price up 30% in the last month. But that can't...
17 Jan, 2020
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...